A Study of Prevalence of EGFR Mutations in Participants With NSCLC

Hoffmann-La Roche69 enrolled

Overview

This is a non-interventional, local, multicenter, cross-sectional study to determine the prevalence of epidermal growth factor receptor (EGFR) mutations in participants diagnosed with non-squamous non-small cell lung cancer (NSCLC).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Non-Small Cell Lung Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Informed consent form signature * Jordanian male and female participants greater than or equal to (\>=) 18 years of age * Histologically confirmed NSCLC * Not participating in a study that involves an investigational agent within 30 days prior to enrollment Exclusion Criteria: * Other primary malignancy * Fine needle aspiration samples

Locations (2)

Unnamed facility

Amman, Jordan

Unnamed facility

Amman, Jordan

Outcomes

Primary Outcomes

Percentage of Participants with EGFR mutations

Time frame: Day 1

Secondary Outcomes

Percentage of Participants with types of EGFR mutations

Time frame: Day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.